SNWV (SANUWAVE Health, Inc. Common Stock)
Insider Trading Activity
Every open-market purchase and sale reported by SNWV officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-02 | Gregory Matthew Bazar | Director | A | — | — |
| 2026-07-02 | Ian D. Miller | Director | A | — | — |
| 2026-07-02 | MORGAN C. FRANK | Chief Executive Officer | A | — | — |
| 2026-07-02 | James Tyler | Director | A | — | — |
| 2026-07-02 | Jeffrey Blizard | Director | A | — | — |
| 2026-05-04 | Opaleye Management Inc. | 10%+ Owner | Sell | — | — |
| 2026-04-21 | Opaleye Management Inc. | 10%+ Owner | Sell | — | — |
| 2026-04-02 | Jeffrey Blizard | Director | A | — | — |
| 2026-04-02 | Gregory Matthew Bazar | Director | A | — | — |
| 2026-04-02 | James Tyler | Director | A | — | — |
| 2026-04-02 | Ian D. Miller | Director | A | — | — |
| 2026-04-02 | MORGAN C. FRANK | Chief Executive Officer | A | — | — |
| 2026-02-03 | MORGAN C. FRANK | Chief Executive Officer | A | — | — |
| 2026-02-03 | David Timothy Wern | Exec VP of Sales | A | — | — |
| 2026-01-06 | James Tyler | Director | A | — | — |
| 2026-01-06 | MORGAN C. FRANK | Chief Executive Officer | A | — | — |
| 2026-01-06 | Gregory Matthew Bazar | Director | A | — | — |
| 2026-01-06 | Ian D. Miller | Director | A | — | — |
| 2026-01-06 | Jeffrey Blizard | Director | A | — | — |
| 2025-12-15 | JAMES E BESSER | — | Sell | — | — |
| 2025-12-11 | MORGAN C. FRANK | 10%+ Owner | Sell | — | — |
| 2025-12-10 | Manchester Explorer, L.P. | — | Sell | — | — |
| 2025-10-09 | Opaleye Management Inc. | 10%+ Owner | Buy | — | — |
| 2025-10-02 | Ian D. Miller | Director | A | — | — |
| 2025-10-02 | Gregory Matthew Bazar | Director | A | — | — |
| 2025-10-02 | James Tyler | Director | A | — | — |
| 2025-10-02 | Jeffrey Blizard | Director | A | — | — |
| 2025-10-02 | MORGAN C. FRANK | Chief Executive Officer | A | — | — |
| 2025-07-02 | Gregory Matthew Bazar | Director | A | — | — |
| 2025-07-02 | Ian D. Miller | Director | A | — | — |
| 2025-07-02 | Jeffrey Blizard | Director | A | — | — |
| 2025-07-02 | James Tyler | Director | A | — | — |
| 2025-07-02 | MORGAN C. FRANK | Chief Executive Officer | A | — | — |
| 2025-06-12 | Anthony Michael Stolarski | Director | MIXED | — | — |
| 2025-06-09 | Peter Stegagno | Chief Operating Officer | MIXED | — | — |
| 2025-05-29 | Gregory Matthew Bazar | Director | A | — | — |
| 2025-05-16 | Iulian Cioanta | Chief Sci. and Tech. Officer | MIXED | — | — |
| 2025-04-30 | Opaleye Management Inc. | 10%+ Owner | Buy | — | — |
| 2025-04-07 | MORGAN C. FRANK | Chief Executive Officer | A | — | — |
| 2025-04-07 | Jeffrey Blizard | Director | A | — | — |
| 2025-04-07 | Ian D. Miller | Director | A | — | — |
| 2025-04-07 | James Tyler | Director | A | — | — |
| 2025-04-07 | Peter Stegagno | Chief Operating Officer | A | — | — |
| 2025-03-24 | Ian D. Miller | Director | A | — | — |
| 2025-03-18 | Jeffrey Blizard | Director | A | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | Chief Executive Officer | 883,390 | — |
| — | Director | 343,286 | — |
| — | — | 85,999 | — |
| — | — | 72,499 | — |
| — | Director | 31,232 | — |
| — | 10%+ Owner | 5,000 | — |
| — | Chief Operating Officer | 3,894 | — |
| — | Chief Sci. and Tech. Officer | 1,818 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the SNWV quote page; the site-wide leaderboard is on the insider transactions hub.